Skip to main content
. 2022 Mar 3;30(8):6405–6418. doi: 10.1007/s00520-022-06921-x

Fig. 3.

Fig. 3

Details of risk of bias assessment of RCTs according to Cochrane RoB 2 tool (intention-to-treat). Treatments include chemotherapy (CTX), therapy with mistletoe extracts (ME), and best supportive care (BSC)